Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL
Squadron Capital Management LLC reported a 5.10% stake in Zentalis Pharmaceuticals, Inc. (Schedule 13G)
Event Feb 24, 2026 · Filed Mar 3, 2026
Squadron Capital Management LLC reported a 5.10% stake in Zentalis Pharmaceuticals, Inc., 3,676,900 shares, as a passive investor on Feb 24, 2026. Filed Mar 3, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 3,676,900
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Squadron Master Fund LP | 5.10% | 3,676,900 |
| Squadron Capital Management LLC | 5.10% | 3,676,900 |
| Matthew Sesterhenn | 5.10% | 3,676,900 |
| William Blank | 5.10% | 3,676,900 |
Source
Related
- Zentalis Pharmaceuticals, Inc.
- Squadron Capital Management LLC
- Zentalis Pharmaceuticals, Inc. shareholders
- Form 4 · Bruns Ingmar · Oct 1, 2026
- Form 4 · Walters William Thurman · Aug 19, 2026
- Schedule 13G/A · Walters Group · Aug 19, 2026
- Schedule 13G/A · Barclays PLC · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026